Mst2 controls bone homeostasis by regulating osteoclast and osteoblast differentiation

Journal of Bone and Mineral Research

Volumn 30, Issue 9, 2015, Pages 1597-1607

  Lee, Jongwon ^a   Youn, Bang Ung ^a   Kim, Kabsun ^a   Kim, Jung Ha ^a   Lee, Da Hye ^b   Seong, Semun ^a   Kim, Inyoung ^a   Han, Seung Hee ^c   Che, Xiangguo ^c   Choi, Je Yong ^c   Park, Yong Wook ^a   Kook, Hyun ^a   Kim, Kyung Keun ^a   Lim, Dae Sik ^b   Kim, Nacksung ^a  

^a Chonnam National University Medical School   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

bone homeostasis; MST2; NF B; osteoblast; osteoclast

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN STERILE 20 LIKE KINASE 2; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; PROTEIN ACP5; PROTEIN ALPL; PROTEIN BGLAP; PROTEIN C FOS; PROTEIN IBSP; PROTEIN NFATC1; PROTEIN OSCAR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; MST2 PROTEIN, MOUSE; NFKB1 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL METABOLIC RATE; BONE HOMEOSTASIS; BONE MASS; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HOMEOSTASIS; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOBLAST DIFFERENTIATION; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRABECULAR BONE; ANIMAL; APOPTOSIS; BONE DEVELOPMENT; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; OSTEOCLAST;

ANIMALS; APOPTOSIS; BONE RESORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HOMEOSTASIS; HUMANS; MALE; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RANK LIGAND; X-RAY MICROTOMOGRAPHY;

EID: 84939568418     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2503     Document Type: Article

References (26)

1. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ., Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999; 20 (3): 345-57.
2. Walsh MC, Kim N, Kadono Y, et al., Osteoimmunology: interplay between the immune system and bone metabolism. Ann Rev Immunol. 2006; 24: 33-63.
3. Danks L, Takayanagi H., Immunology and bone. J Biochem. 2013; 154 (1): 29-39.
4. Kim K, Kim JH, Lee J, et al., Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem. 2005; 280 (42): 35209-16.
5. Kamiya N., The role of BMPs in bone anabolism and their potential targets SOST and D KK1. Curr Mol Pharmacol. 2012; 5 (2): 153-63.
6. Komori T., Signaling networks in RUNX2-dependent bone development.J Cell Biochem. 2011; 112 (3): 750-5.
7. Komori T, Yagi H, Nomura S, et al., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89 (5): 755-64.
8. Otto F, Thornell AP, Crompton T, et al., Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89 (5): 765-71.
9. Greenblatt MB, Shim JH, Glimcher LH., Mitogen-activated protein kinase pathways in osteoblasts. Ann Rev Cell Dev Biol. 2013; 29: 63-79.
10. Novack DV., Role of NF-kappaB in the skeleton. Cell Res. 2011; 21 (1): 169-82.
11. Boyce BF, Yao Z, Xing L., Functions of nuclear factor kappaB in bone. Ann NY Acad Sci. 2010; 1192: 367-75.
12. Ling P, Lu TJ, Yuan CJ, Lai MD., Biosignaling of mammalian Ste20-related kinases. Cell Signal. 2008; 20 (7): 1237-47.
13. Qin F, Tian J, Zhou D, Chen L., Mst1 and Mst2 kinases: regulations and diseases. Cell Biosci. 2013; 3 (1): 31.
14. Zeng Q, Hong W., The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell. 2008; 13 (3): 188-92.
15. Callus BA, Verhagen AM, Vaux DL., Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006; 273 (18): 4264-76.
16. Matsumoto H, Murakami Y, Kataoka K, et al., Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment. Cell Death Dis. 2014; 5: e 1269.
17. Oh S, Lee D, Kim T, et al., Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol Cell Biol. 2009; 29 (23): 6309-20.
18. Oh HJ, Lee KK, Song SJ, et al., Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res. 2006; 66 (5): 2562-9.
19. Kim N, Takami M, Rho J, Josien R, Choi Y., A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med. 2002; 195 (2): 201-9.
20. Asagiri M, Takayanagi H., The molecular understanding of osteoclast differentiation. Bone. 2007; 40 (2): 251-64.
21. Lee ZH, Kim HH., Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003; 305 (2): 211-4.
22. Harvey KF, Zhang X, Thomas DM., The Hippo pathway and human cancer. Nat Rev Cancer. 2013; 13 (4): 246-57.
23. Hayden MS, Ghosh S., Signaling to NF-kappaB. Genes Dev. 2004; 18 (18): 2195-224.
24. Chang J, Wang Z, Tang E, et al., Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med. 2009; 15 (6): 682-9.
25. Hirata-Tsuchiya S, Fukushima H, Katagiri T, et al., Inhibition of BMP2-induced bone formation by the p65 subunit of NF-kappaB via an interaction with Smad4. Mol Endocrinol. 2014; 28 (9): 1460-70.
26. Song H, Kim H, Lee K, et al., Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice. EMBO J. 2012; 31 (5): 1147-59.